explore -WSS

explore

author：hotspot 2025-09-27 09:44:44 - browse：4416

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： When prostate cancer spreads, where it goes matters

leisure time

WSS

When prostate cancer spreads, where it goes matters

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Venture capitalist Bob Kocher on the state of digital health

Midwives could help bridge maternal health disparities in the U.S.

Information blocking fines are now fair game in health care

Readers respond to H5N1 and livestock movements, and more

focus

explore

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Senate bill would ban some hospital facility fees

New air purifier tech could be key to improving indoor air quality

Midwives could help bridge maternal health disparities in the U.S.

After affirmative action ruling, medical educators look to 'holistic review'

It's time to retire 'poor historian' from clinicians' vocabularies

What does generative AI mean for health care? We asked experts

Why the quest to eradicate polio has stumbled

Peter Hotez and the public health issue of online harassment

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

hotspot

Criminal prosecution for violating HIPAA: an emerging threat

Patients, doctors press FTC to beef up hospital merger scrutiny

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Information blocking fines are now fair game in health care

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

leisure time

leisure time

entertainment

hotspot